Skip to main content
Baseline DCP levels and NLR predict survival in patients receiving atezolizumab+bevacizumab for advanced HCC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Baseline DCP levels and NLR predict survival in patients receiving atezolizumab+bevacizumab for advanced HCC
User login
Username
Password
Reset your password
Concept
Lead
score
Hepatocellular Carcinoma
1
1
Cancer
0
0.67
Biologic Therapy
0
0.64
Angiogenesis Inhibitors
0
0.45
Biomarker
0
0.45
Humanized Monoclonal Antibody
0
0.45
Lymphocytes
0
0.22
Neutrophils
0
0.22
Specialty
Lead
score
Hematology-Oncology
1
1
Gastroenterology
0
1
Family Medicine/Primary Care
0
0.74
Edit Tags